Search Clinical Trials
| Sponsor Condition of Interest |
|---|
|
ShotBlocker During Intramuscular Injection Randomized Control Trial
Lauren Fortier
Neonatal Pain
The objective of this trial is to evaluate the effect of Bionix ShotBlocker on pain of
injection of the first Hepatitis B vaccine in healthy newborns. ShotBlocker is a pain
reducing tool used in babies, children, and adults for injections. Swaddling during the
injection and administration of oral s1 expand
The objective of this trial is to evaluate the effect of Bionix ShotBlocker on pain of injection of the first Hepatitis B vaccine in healthy newborns. ShotBlocker is a pain reducing tool used in babies, children, and adults for injections. Swaddling during the injection and administration of oral sucrose prior to the injection are established standards of care for painful procedures in neonates. The investigators hypothesize that the use of ShotBlocker in addition to swaddling and oral sucrose administration will lessen the pain response. Type: Interventional Start Date: Jan 2024 |
|
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Carna Biosciences, Inc.
B-cell Malignancy
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Waldenstrom Macroglobulinemia
Mantle Cell Lymphoma
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763
(docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant
to ≥2 lines of systemic therapy. expand
This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ≥2 lines of systemic therapy. Type: Interventional Start Date: Aug 2023 |
|
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patient1
Surgimab
Colorectal Neoplasms
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of
standard "white light" visualization during surgical resections of colorectal cancer. expand
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer. Type: Interventional Start Date: Jun 2019 |